Contact Us

Lexitas Resource Library

Lexitas Ophthalmology CRO added to Octane Preferred Advisors

Octane Welcomes Lexitas Pharma Services as Newest Octane Preferred Advisor

Read Full Article
Lexitas Announces Acquisition of Erie Retina Research

Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie

Read More
Lexitas and NAMSA announce strategic partnership for ophthalmic medical device development

Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

Read More

Events

Meet Lexitas at Clinical Trials at the Summit

Clinical Trials @ The Summit

View Event

Additional Resources

Lexitas Ophthalmology CRO added to Octane Preferred Advisors

Octane Welcomes Lexitas Pharma Services as Newest Octane Preferred Advisor

Read More
Lexitas Announces Acquisition of Erie Retina Research

Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie

Read More
Lexitas and NAMSA announce strategic partnership for ophthalmic medical device development

Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

Read More
Cell & Gene Therapy in Ophthalmology

Webinar: Cell & Gene Therapy in Ophthalmology

Read More
A Vision for Growth by Jeanne Hecht and David Tanzer, MD

A Vision for Growth

Read More
Expanding horizons: Why ophthalmology practices should consider embracing clinical trials

Expanding horizons: Why ophthalmology practices should consider embracing clinical trials

Read More